• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液灌流在神经性毒剂实验性中毒中的应用。

Use of hemoperfusion in experimental intoxication with nerve agents.

作者信息

Monhart V, Fusek J, Brndiar M, Tlustakova M

机构信息

Third Department of Internal Medicine, Central Army Hospital, Prague, Czech Republic.

出版信息

Artif Organs. 1994 Oct;18(10):770-2. doi: 10.1111/j.1525-1594.1994.tb03317.x.

DOI:10.1111/j.1525-1594.1994.tb03317.x
PMID:7832660
Abstract

The aim of this study was to evaluate the efficiency of hemoperfusion (HP) through coated resin adsorbent Synachrom E-5 in animal intoxications with organophosphate inhibitors of cholinesterases type of nerve agents. Five anesthetized dogs were intoxicated with 2 to 6 LD50 of VX substance and another 4 with 2 to 3 LD50 sarine. Both nerve agents were given i.m. after starting 5 h HP. The clinical and laboratory tests were monitored during each HP. HP therapy prevented the development of serious signs of intoxication provided that the administered quantity of both sarine and the VX substance was only 2 doses of LD50. Specific antidote therapy was necessary to prevent cardiorespiratory failure in animals intoxicated with a higher dose of poison. The results obtained show that HP through Synachrom E-5 in intoxication with nerve agents sarine and the VX type is only partially successful.

摘要

本研究的目的是评估通过涂覆树脂吸附剂Synachrom E-5进行血液灌流(HP)对动物因神经毒剂类型的有机磷酸酯胆碱酯酶抑制剂中毒的疗效。五只麻醉犬用2至6倍半数致死剂量(LD50)的VX物质中毒,另外四只用2至3倍LD50的沙林中毒。两种神经毒剂均在开始血液灌流5小时后肌肉注射。在每次血液灌流期间监测临床和实验室检查。只要给予的沙林和VX物质的量仅为2倍LD50剂量,血液灌流治疗就能防止严重中毒症状的出现。对于中毒剂量较高的动物,需要进行特异性解毒剂治疗以预防心肺衰竭。所获得的结果表明,通过Synachrom E-5进行血液灌流对沙林和VX型神经毒剂中毒仅部分成功。

相似文献

1
Use of hemoperfusion in experimental intoxication with nerve agents.血液灌流在神经性毒剂实验性中毒中的应用。
Artif Organs. 1994 Oct;18(10):770-2. doi: 10.1111/j.1525-1594.1994.tb03317.x.
2
Evaluation of reactivation test in anaesthetized dogs with experimental intoxication with nerve agents.对实验性神经毒剂中毒的麻醉犬进行再激活试验的评估。
J Appl Toxicol. 2006 Sep-Oct;26(5):439-43. doi: 10.1002/jat.1158.
3
Therapeutic efficacy of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) against organophosphate intoxication.腺苷A1受体激动剂N6-环戊基腺苷(CPA)对有机磷中毒的治疗效果。
Arch Toxicol. 2002 Nov;76(11):650-6. doi: 10.1007/s00204-002-0395-x. Epub 2002 Aug 21.
4
Therapeutic effects of new oximes, benactyzine and atropine in Soman poisoning: Part I. Effects of various oximes in Soman, Sarin, and Vx poisoning in dogs.新型肟类化合物、苯那辛和阿托品对梭曼中毒的治疗作用:第一部分。各种肟类化合物对犬梭曼、沙林和维埃克斯中毒的作用
Fundam Appl Toxicol. 1981 Mar-Apr;1(2):161-3. doi: 10.1016/s0272-0590(81)80053-x.
5
Cardiorespiratory function in nerve agent poisoned and oxime + atropine treated guinea-pigs: effect of pyridostigmine pretreatment.
Arch Toxicol. 1995;69(5):322-9. doi: 10.1007/s002040050178.
6
A comparison of the efficacy of HI6 and 2-PAM against soman, tabun, sarin, and VX in the rabbit.HI6和2-吡啶醛肟甲基氯化物对兔体内梭曼、塔崩、沙林和VX的疗效比较。
Toxicol Lett. 1994 Feb 15;70(3):269-79. doi: 10.1016/0378-4274(94)90121-x.
7
Successful pretreatment/therapy of soman, sarin and VX intoxication.梭曼、沙林和VX中毒的成功预处理/治疗。
Drug Chem Toxicol. 1992;15(4):271-83. doi: 10.3109/01480549209014157.
8
A case of VX poisoning and the difference from sarin.一例VX中毒病例及与沙林的区别。
Lancet. 1995 Sep 9;346(8976):698-9.
9
Combined hemoperfusion and hemodialysis treatment of poisoning with cholinesterase inhibitors.血液灌流联合血液透析治疗胆碱酯酶抑制剂中毒
Korean J Intern Med. 1993 Jul;8(2):99-102. doi: 10.3904/kjim.1993.8.2.99.
10
The influence of inhibitors and other factors on cholinesterases.抑制剂及其他因素对胆碱酯酶的影响。
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove. 1991;34(1):5-77.

引用本文的文献

1
Advances in toxicology and medical treatment of chemical warfare nerve agents.毒理学和化学战剂医学治疗的进展。
Daru. 2012 Nov 28;20(1):81. doi: 10.1186/2008-2231-20-81.